Literature DB >> 12060606

New HER2-directed therapies for breast cancer. Commentary re: C. I. Spiridon et al., Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity. Clin. Cancer Res., 8: 1720-1730, 2002.

Arthur E Frankel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060606

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  2 in total

1.  A quantitative study on the photothermal effect of immuno gold nanocages targeted to breast cancer cells.

Authors:  Leslie Au; Desheng Zheng; Fei Zhou; Zhi-Yuan Li; Xingde Li; Younan Xia
Journal:  ACS Nano       Date:  2008-08       Impact factor: 15.881

2.  A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling.

Authors:  Tsung-Hua Hsieh; Chia-Yi Hsu; Cheng-Fang Tsai; Chien-Chih Chiu; Shih-Shin Liang; Tsu-Nai Wang; Po-Lin Kuo; Cheng-Yu Long; Eing-Mei Tsai
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.